Protocol for a patient-derived preclinical platform to model tumor-immune interactions and evaluate therapeutic efficacy
Summary: Here, we present a protocol for a preclinical ex vivo platform combining experimental flexibility with preservation of the tumor microenvironment. We outline steps for isolating human peripheral blood mononuclear cells (PBMCs), preparing patient-derived precision-cut tumor slices (PCTSs), c...
Saved in:
Main Authors: | Wen-Hsin Chang, Andrew I. Chin, Ching-Hsien Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-03-01
|
Series: | STAR Protocols |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666166725000292 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Protocol for predicting the single-cell network-based gene activity landscape during human B cell development
by: Xin Huang, et al.
Published: (2025-03-01) -
Protocols for the application of human embryonic stem cell-derived neurons for aging modeling and gene manipulation
by: Hui Zhang, et al.
Published: (2025-03-01) -
Protocol for odorant-binding protein 2A gene knockdown by dual siRNA transfection in a three-dimensional human epidermal equivalent model
by: Shinobu Nakanishi
Published: (2025-03-01) -
Protocol for the purification and analysis of nuclear UFMylated proteins
by: Pudchalaluck Panichnantakul, et al.
Published: (2025-03-01) -
Protocol for the site-specific isolation of mouse endothelial cells using the modified Häutchen technique
by: Alexander Brückner, et al.
Published: (2025-03-01)